Literature DB >> 21985069

Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19.

Jonathan P Caulkins1, Beau Kilmer, Robert J MacCoun, Rosalie Liccardo Pacula, Peter Reuter.   

Abstract

AIMS: No modern jurisdiction has ever legalized commercial production, distribution and possession of cannabis for recreational purposes. This paper presents insights about the effect of legalization on production costs and consumption and highlights important design choices.
METHODS: Insights were uncovered through our analysis of recent legalization proposals in California. The effect on the cost of producing cannabis is largely based on existing estimates of current wholesale prices, current costs of producing cannabis and other legal agricultural goods, and the type(s) of production that will be permitted. The effect on consumption is based on production costs, regulatory regime, tax rate, price elasticity of demand, shape of the demand curve and non-price effects (e.g. change in stigma).
RESULTS: Removing prohibitions on producing and distributing cannabis will dramatically reduce wholesale prices. The effect on consumption and tax revenues will depend on many design choices, including: the tax level, whether there is an incentive for a continued black market, whether to tax and/or regulate cannabinoid levels, whether there are allowances for home cultivation, whether advertising is restricted, and how the regulatory system is designed and adjusted.
CONCLUSIONS: The legal production costs of cannabis will be dramatically below current wholesale prices, enough so that taxes and regulation will be insufficient to raise retail price to prohibition levels. We expect legalization will increase consumption substantially, but the size of the increase is uncertain since it depends on design choices and the unknown shape of the cannabis demand curve.
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction.

Mesh:

Substances:

Year:  2011        PMID: 21985069     DOI: 10.1111/j.1360-0443.2011.03561.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  25 in total

1.  An examination of opinions toward marijuana policies among high school seniors in the United States.

Authors:  Joseph J Palamar
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  Cannabis legalization: adhering to public health best practice.

Authors:  Sheryl Spithoff; Brian Emerson; Andrea Spithoff
Journal:  CMAJ       Date:  2015-09-21       Impact factor: 8.262

3.  The potential impact of cannabis legalization on the development of cannabis use disorders.

Authors:  Alan J Budney; Jacob T Borodovsky
Journal:  Prev Med       Date:  2017-06-28       Impact factor: 4.018

4.  U.S. cannabis legalization and use of vaping and edible products among youth.

Authors:  Jacob T Borodovsky; Dustin C Lee; Benjamin S Crosier; Joy L Gabrielli; James D Sargent; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2017-06-09       Impact factor: 4.492

5.  Implications of marijuana legalization for adolescent substance use.

Authors:  Christian Hopfer
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

Review 6.  Cannabis use, attitudes, and legal status in the U.S.: A review.

Authors:  Hannah Carliner; Qiana L Brown; Aaron L Sarvet; Deborah S Hasin
Journal:  Prev Med       Date:  2017-07-11       Impact factor: 4.018

7.  How Medical Marijuana Smoothed the Transition to Marijuana Legalization in the United States.

Authors:  Beau Kilmer; Robert J MacCoun
Journal:  Annu Rev Law Soc Sci       Date:  2017-07-03

8.  Marijuana Legalization and Parents' Attitudes, Use, and Parenting in Washington State.

Authors:  Rick Kosterman; Jennifer A Bailey; Katarina Guttmannova; Tiffany M Jones; Nicole Eisenberg; Karl G Hill; J David Hawkins
Journal:  J Adolesc Health       Date:  2016-08-11       Impact factor: 5.012

9.  High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization.

Authors:  Jennifer K Carah; Jeanette K Howard; Sally E Thompson; Anne G Short Gianotti; Scott D Bauer; Stephanie M Carlson; David N Dralle; Mourad W Gabriel; Lisa L Hulette; Brian J Johnson; Curtis A Knight; Sarah J Kupferberg; Stefanie L Martin; Rosamond L Naylor; Mary E Power
Journal:  Bioscience       Date:  2015-06-19       Impact factor: 8.589

10.  Evidence-based drug policy: it starts with good evidence and ends with policy reform.

Authors:  B Nosyk; E Wood
Journal:  Int J Drug Policy       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.